Press release
Global Antiviral Drugs Market is Expected to Reach USD 37.40 billion, from 2016 to 2021
Market data forecast
Antiviral drugs are described as curative or disease controlling agents against viral infections. These drugs specifically attack viruses at different metabolic processes and alter the normal functioning of viral particles. From the past few years resistance is observed among viruses against different antiviral drugs with increasing diversity of viruses. This challenge leads to the evolution of broad spectrum antiviral drugs that specifically attack viruses at specified targets such as DNA Polymerase, NS3 Protease, & Reverse Transcriptase. These drugs are used to prevent or cure different viral infections such as HIV/AIDS, Hepatitis, influenza, and other viral infections.
Request Sample: http://www.marketdataforecast.com/market-reports/global-antiviral-drugs-market-1587/request-sample
The main driver which adds fuel to the market is increasing incidence rates of viral infections, such as according to World Health Organization, HIV/AIDS continues to be the major threat claiming more than 35 million lives so far. Globally, approximately 1.1 million lost their lives due to HIV in 2015. Approximately, 36.7 million people have been suffering from HIV in 2015.
Furthermore, as late stage pipeline drugs are anticipated to hit the market, this further supports the antiviral drugs market growth
The factors affecting the Global Market for Antiviral Drugs Market, either positively or negatively are presented in the DROC analysis. Some of the factors discussed in this section are increase in public awareness, rise in healthcare expenditure, boost in Research and Development segment, emergence of life-threatening diseases, growing interest to support the development of novel antiviral drugs, existence of well-established supply chain, high cost involved in drug development, increase in demand for alternative medicines (naturopathy, homeopathy, and oriental medicines), growing resistance among viruses against different antiviral drugs causing difficulty in developing broad-spectrum anti-viral drugs, restricted trade policies, lack of incentivization, and side-effects of products (nausea, diarrhea, and behavioral changes). In addition, increasing incidence rates of viral infections is also fuelling the antiviral drugs market growth are also added.
For granular level understanding the Antiviral Drugs Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segment.
1) By Application:
• Introduction
• HIV/AIDS
• Hepatitis
• Herpes
• Influenza
• Others
• Y-o-Y Growth Analysis, By Application
• Market Attractiveness Analysis, By Application
• Market Share Analysis, By Application
2) By Target:
• Introduction
• DNA polymerase
• NS3 Protease
• Reverse transcriptase
• Others
• Y-o-Y Growth Analysis, By Target
• Market Attractiveness Analysis, By Target
• Market Share Analysis, By Target
3) By End Users:
• Introduction
• Hospitals/Clinics
• Research Institutes
• Laboratory Centers
• Y-o-Y Growth Analysis, By End Users
• Market Attractiveness Analysis, By End Users
• Market Share Analysis, By End User
Customized report URL: http://www.marketdataforecast.com/market-reports/global-antiviral-drugs-market-1587/customize-report
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 34.0% in the global antiviral drugs market. Whereas, Asia-Pacific is projected to grow at the highest CAGR of 6.12% during forecast period 2016-2021.For more of regional analysis check out the following reports.
• North America Antiviral Drugs Market
• Europe Antiviral Drugs Market
• Asia-Pacific Antiviral Drugs Market
• Latin America Antiviral Drugs Market
• Middle East and Africa Antiviral Drugs Market
The major companies dominating the global Antiviral Drugs market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
The Global Antiviral Drugs Market study offers the following deliverables:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming
• Segment-level analysis on basis of type, application, end-user along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of macro and micro environmental factors that effect the global market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
• A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Bladder Cancer Therapeutics Market: http://www.marketdataforecast.com/market-reports/global-bladder-cancer-therapeutics-market-1149/
Cancer Monoclonal Antibodies Market: http://www.marketdataforecast.com/market-reports/global-cancer-monoclonal-antibodies-market-185/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Antiviral Drugs Market is Expected to Reach USD 37.40 billion, from 2016 to 2021 here
News-ID: 598870 • Views: …
More Releases from Market Data Forecast
Business Management Consulting Service Market is expected to witness a significa …
According to the latest research report published by Market Data Forecast, the global business management consulting services market is estimated to grow at a CAGR of 4.3% from 2024 to 2029 and be worth USD 1148 bn by 2029 from USD 930.15 bn in 2024.
The demand for consulting services is fuelled by the need for outside help from several enterprises, charitable organizations, and government agencies. Business management consulting advises organizations…
Antimicrobial Coatings Market expected to witness a significant growth rate of 1 …
According to the latest research report published by Market Data Forecast, the global antimicrobial coatings market is expected to grow at a CAGR of 11% during the forecast period 2024-2029. The market value was at USD 5 billion in 2023 and the value is expected to reach USD 9 billion by the end of 2029.
It is applied to stop microorganisms and other bacteria from growing and expanding. These are extensively…
End-User Computing Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the global end-user computing market is predicted to reach USD 15.33 billion in 2024 and USD 27.99 billion in 2029, growing at a CAGR of 12.8% during the forecast period.
Today's workforce is moving, with employees looking to access corporate data, apps, and online resources across more devices and locations. While supporting workplace mobility, minimizing risk, and maintaining compliance, end-user…
Smart Homes Market Size, Share, Growth Report 2024-2029
According to the latest research report published by Market Data Forecast, the global smart home market is predicted to reach USD 114.92 billion in 2024 and USD 221.46 billion by 2029, growing at a CAGR of 14.02% during the forecast period.
Advancements in IoT technology, as well as rising consumer demand for convenience and energy efficiency, are driving significant growth in the smart home industry. Smart thermostats, lighting, security systems, and…
More Releases for Antiviral
Global Antiviral Therapeutics Market Size - By Product Type(Herpes Antiviral Dru …
Antiviral Therapeutics Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Antiviral Therapeutics Market Scope: Unveiling Today's Trends
Antiviral therapeutics are medications designed to treat viral infections by inhibiting viral replication and mitigating symptoms. The Antiviral Therapeutics market is experiencing significant growth, driven by the increasing prevalence of viral diseases, ongoing research and development, and the ongoing impact of emerging viral outbreaks. Key trends include a rising focus on personalized medicine and…
Antiviral Drugs Market: Advancements in Antiviral Drugs - Analysis by Medical Ex …
Allied Market Research recently said Antiviral drugs have been at the forefront of medical advancements, offering effective treatment and prevention options against a wide range of viral infections. These pharmaceutical agents are specifically designed to target and inhibit the replication of viruses, helping to control the spread of viral diseases and improve patient outcomes. In recent years, significant progress has been made in the development of antiviral drugs, revolutionizing the…
Antiviral Drugs Market
“Antiviral Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.
This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market…
Antiviral therapies Market: High Cost of Antiviral therapies Is a Major Restrain …
Post COVID-19 Impact on Antiviral Therapies Market –With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues. Research Dive’ group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive…
Coronavirus's Impact On Antiviral Packaging Market
Antiviral Packaging Market – An Overview
The coronavirus pandemic keeps on revamping the idea of worldwide society in 2020, and with it changes the perspectives and practices of buyers now and for a long time to come. In any case, the prompt effect on buyers’ interests about viral introduction and questions hanging about the infection’s capacity to make due on surfaces, may fuel an any longer enduring interest for new bundling…
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an…
